ArticleFrontiers in pharmacology2023

Ustekinumab trough levels in children with Crohn's disease refractory to anti-tumor necrosis factor agents: a prospective case series of off-label use.

Marleen Bouhuys et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.